Work

P1.13-43 Molecular and Imaging Predictors of Response to Ado-Trastuzumab Emtansine in Patients with HER2 Mutant Lung Cancers: An Exploratory Phase 2 Trial

Year: 2018

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.08.900

Authors: B. Li, M. Offin, T. Hembrough, F. Cecchi, R. Shen, Z. Olah, E. Panora, M. Myers, E. Brzostowski, D. Buonocore, M. Ginsberg, C. Rudin, M. Kris, G. Weitsman, P. Barber, T. Ng, G. Ulaner, M. Arcila, M. Scaltriti

Institutions: Memorial Sloan Kettering Cancer Center, NantOmics LLC (United States), King's College London

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2898596331

FWCI: 0.507

Cites:

Cited by: 5

Related to: 10